Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.31 |
| ▸ | MVD | P53602 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3424447 | 0.86 | MEN1 (0.36) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL3422757 | 0.83 | FDPS (0.42) | TDP1FDPS | |
| SCHEMBL10716346 | 0.82 | FOLH1 (0.34) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL10716340 | 0.82 | FOLH1 (0.34) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL9833755 | 0.81 | FDPS (0.38) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL6903724 | 0.81 | CA2 (0.34) | FDPSCA2 | |
| SCHEMBL124790 | 0.80 | TDP1 (0.39) | LMNATSHRBLMTDP1 | |
| SCHEMBL10482435 | 0.79 | MVD (0.32) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL29420575 | 0.78 | FDPS (0.33) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL10891571 | 0.78 | TDP1 (0.38) | LMNATSHRBLMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9120081-B2 | Transition metal-containing catalysts and processes for their preparation and use as oxidation and dehydrogenation catalysts | MONSANTO TECHNOLOGY LLC (US) | 2015-09-01 | — | — | US | disclosed |
| US-20140235432-A1 | Transition Metal-Containing Catalysts and Processes for Their Preparation and Use As Oxidation and Dehydrogenation Catalysts | MONSANTO TECHNOLOGY LLC (US) | 2014-08-21 | — | — | US | disclosed |
| US-8697904-B2 | Transition metal-containing catalysts and processes for their preparation and use as oxidation and dehydrogenation catalysts | MONSANTO TECHNOLOGY LLC (US) | 2014-04-15 | — | — | US | disclosed |
| US-8450523-B2 | Process for preparation of a carboxylic acid salt by dehydrogenation of a primary alcohol | MONSANTO TECHNOLOGY LLC (US) | 2013-05-28 | — | — | US | disclosed |
| US-8298985-B2 | Catalyst for dehydrogenating primary alcohols | MONSANTO TECHNOLOGY LLC (US) | 2012-10-30 | — | — | US | disclosed |
| EP-1272451-B1 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | MONSANTO TECHNOLOGY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20120190889-A1 | PROCESS FOR PREPARATION OF A CARBOXYLIC ACID SALT BY DEHYDROGENATION OF A PRIMARY ALCOHOL | MONSANTO TECHNOLOGY LLC (US) | 2012-07-26 | — | — | US | disclosed |
| EP-2460586-A2 | Process for oxidation of N-(phosphonomethyl)iminodiacetic acid or salt thereof | Monsanto Technology LLC (US) | 2012-06-06 | — | — | EP | disclosed |
| US-20110301381-A1 | Transition Metal-Containing Catalysts and Processes for Their Preparation and Use As Oxidation and Dehydrogenation Catalysts | MONSANTO TECHNOLOGY LLC (US) | 2011-12-08 | — | — | US | disclosed |
| US-7932419-B2 | Transition metal-containing catalysts and processes for their preparation and use as oxidation and dehydrogenation catalysts | MONSANTO TECHNOLOGY LLC (US) | 2011-04-26 | — | — | US | disclosed |
| US-20050043566-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | MONSANTO TECHNOLOGY LLC | 2005-02-24 | — | — | US | disclosed |
| WO-2005016519-A1 | TRANSITION METAL-CARBIDE AND NITRIDE CONTAINING CATALYSTS , THEIR PREPARATION AND USE AS OXIDATION AND DEHYDROGENATION CATALYSTS | MONSANTO TECHNOLOGY LLC (US) | 2005-02-24 | — | — | WO | disclosed |
| EP-1436080-A2 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | Monsanto Technology LLC (US) | 2004-07-14 | — | — | EP | disclosed |
| US-6706662-B2 | CATALYST COMPRISING: A METAL SUPPORT COMPRISING COPPER AND A NON-COPPER METAL; AND A COPPER-CONTAINING COATING IN SPECIFIED AMOUNTS OF COPPER; MAKING N-(PHOSPHONOMETHYL)GLYCINE FROM MONOETHANOLAMINE | MONSANTO TECHNOLOGY LLC | 2004-03-16 | — | — | US | disclosed |
| WO-2003033140-A2 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | MONSANTO TECHNOLOGY LLC (US) | 2003-04-24 | — | — | WO | disclosed |
| EP-1272451-A2 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | Monsanto Technology LLC (US) | 2003-01-08 | — | — | EP | disclosed |
| US-20020161259-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | MONSANTO COMPANY | 2002-10-31 | — | — | US | disclosed |
| US-6376708-B1 | USING COPPER, OR ALLOY THEREOF, AS CATALYST | MONSANTO TECHNOLOGY LLC | 2002-04-23 | — | — | US | disclosed |
| US-20020019564-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | MONSANTO COMPANY | 2002-02-14 | — | — | US | disclosed |
| WO-2001077054-A2 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | MONSANTO TECHNOLOGY LLC (US) | 2001-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043566-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | ADH1A, ADH1C, ADH5 | MEN1 858/4885LMNA 2729/4885HPGD 158/4885 |
| US-20120190889-A1 | PROCESS FOR PREPARATION OF A CARBOXYLIC ACID SALT BY DEHYDROGENATION OF A PRIMARY ALCOHOL | ADH1A, ADH1C, ADH5 | MEN1 1194/4885LMNA 3425/4885HPGD 180/4885 |
| US-20020161259-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | ADH1A, ADH1C, ADH5 | MEN1 2305/4885LMNA 4650/4885HPGD 191/4885 |
| US-20110301381-A1 | Transition Metal-Containing Catalysts and Processes for Their Preparation and Use As Oxidation and Dehydrogenation Catalysts | ADH1A, ADH1C, ADH5 | MEN1 727/4885LMNA 2391/4885HPGD 211/4885 |
| US-20020019564-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | ADH1A, ADH1C, ADH5 | MEN1 2036/4885LMNA 3280/4885HPGD 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.